IP Library › Granted Patent US 10,894,163
Granted Patent B2
US 10,894,163 · App. 15/805,239 · Granted Jan 19, 2021

LCP based predictive timing for cardiac resynchronization

Inventor: Jeffrey E. Stahmann (Ramsey, MN)
Assignee: CARDIAC PACEMAKERS, INC.
A61N1/36585A61N1/0587A61N1/3622A61N1/3627A61N1/3682A61N1/36507A61N1/3756A61N1/37235A61N1/37288A61N1/37512
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,894,163
App. No.
15/805,239
Granted
Jan 19, 2021
Kind
B2
Abstract

Methods, systems and devices for providing cardiac resynchronization therapy (CRT) to a patient using a leadless cardiac pacemaker (LCP) implanted in or proximate the left ventricle of a patient. A setup phase is used to establish parameters in the therapy delivery. In operation, the method and/or device will sense at least one non-paced cardiac cycle to determine a native R-R interval, and then delivers a synchronization pace at an interval less than the native R-R interval followed by a plurality of pace therapies delivered at the R-R interval or a modification thereof.

Claims (47)

1. A leadless cardiac pacemaker (LCP) configured for implantation entirely within a heart chamber of a patient or adjacent to a heart chamber of a patient, the LCP comprising:

a plurality of electrodes for cardiac therapy delivery and cardiac electrical sensing;

pacing circuitry configured to generate pacing therapy outputs; and

control circuitry configured to analyze signals from the electrodes and to control the use of the pacing circuitry for cardiac resynchronization therapy (CRT);

wherein the control circuitry is configured for:

sensing a native R-R interval from the patient's heart;

calculating a synchronization interval by reducing the native R-R interval using a reduction factor;

sensing a native ventricular event;

delivering a synchronization pace therapy upon expiration of the synchronization interval following the native ventricular event; and

delivering a predetermined number, N, of additional pace therapies at intervals approximately equal to the native R-R interval.

2. The LCP of claim 1 , wherein the control circuitry is configured to provide the CRT without using an atrial sense reference.

3. The LCP of claim 1 , wherein the control circuitry is configured to perform an initialization of CRT to determine the reduction factor by:

determining a PR interval for the patient's cardiac activity; and

multiplying the PR interval by a variable, % PR, to calculate the reduction factor.

4. The LCP of claim 1 , wherein the control circuitry is configured to perform an initialization of CRT to determine the reduction factor by:

sensing one or more native ventricular events to calculate an RR interval between native ventricular events and a PR interval within one or more native ventricular events;

calculating a RR:PR ratio as a ratio of the RR interval to the PR interval;

obtaining a variable, % PR, from memory or from an external programmer; and

calculating the reduction factor as one minus the product of the first variable and the % PR; and

further wherein the control circuitry is configured to calculate the synchronization interval by multiplying the reduction factor and the native beat interval.

5. The LCP of claim 1 , wherein the control circuitry is configured to perform an initialization of CRT to determine the reduction factor by:

sensing one or more native ventricular events to calculate an RR interval between native ventricular events;

communicating with a second device to determine when P-waves occurred in the one or more native ventricular events and calculating a PR interval;

calculating a RR:PR ratio as a ratio of the RR interval to the PR interval;

obtaining a variable, % PR, from memory or from an external programmer; and

calculating the reduction factor as one minus the product of the first variable and the % PR; and

further wherein the control circuitry is configured to calculate the synchronization interval by multiplying the reduction factor and the native beat interval.

6. The LCP of claim 1 , wherein the control circuitry is configured to monitor patient status and make adjustments to the CRT including:

sensing for a patient condition that would influence the reduction factor;

detecting a change in the patient condition; and

adjusting the reduction factor.

7. The LCP of claim 1 , further comprising a posture sensor, wherein the control circuitry is configured to monitor patient posture and make adjustments to the CRT including:

sensing a posture of the patient;

determining whether the patient has changed postures; and

in response to finding that the patient has changed postures, adjusting the reduction factor.

8. The LCP of claim 1 , wherein the control circuitry is configured to monitor patient status and make adjustments to the CRT including sensing for a predetermined patient condition that may influence PR interval, and in response to sensing the predetermined patient condition, adjusting “N”.

9. The LCP of claim 1 , further comprising a posture sensor, wherein the control circuitry is configured to monitor patient posture and make adjustments to the CRT including:

sensing a posture of the patient;

determining that the patient has changed postures between standing and one of sitting or laying down; and:

if the patient has gone from standing to sitting or laying down, increasing “N”; or

if the patient has gone from sitting or laying down to standing, reducing “N”.

10. The LCP of claim 1 , wherein the control circuitry is configured to iteratively provide the CRT in sets and to adjust N after delivery of a plurality of sets by:

observing changes in native R-R intervals, to calculate an R-R drift; and

calculating N using the calculated drift.

11. The LCP of claim 1 , wherein the control circuitry is configured for at least first and second modes of CRT therapy wherein:

the first mode comprises delivering sets of CRT therapy via the combination of sensing a native R-R interval, delivering a synchronization pace therapy, and delivering a plurality of additional pace therapies;

the second mode comprises obtaining atrial event timing information from a second implantable or wearable medical device to control or optimize pace therapy timing.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2017
From: STAHMANN, JEFFREY E.
To: CARDIAC PACEMAKERS, INC.
Reel/Frame 044088/0276 →
Continuity (2)
Provisional Application 62424582 · Nov 21, 2016
Related Publication 20180140848A1 · May 24, 2018
Cited By (4)
US 12,357,792 US 12,440,656 US 12,654,018 US 12,661,487